Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 252-173-9 | CAS number: 34730-59-1
Carcinogenicity
Administrative data
Description of key information
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
No classification with regard to carcinogenicity is required.
Additional information
No carcinogenicity studies are available for AAS. However, the substance did not show mutagenic effects in several mutagenicity tests and was shown to be of low toxicity in repeated dose toxicity studies. Therefore, a carcinogenic potential of AAS can be considered unlikely.
Justification for selection of carcinogenicity via oral route endpoint:
No carcinogenicity study is required since the substance is not a mutagen and no hyperplasia or pre-neoplastic lesions were observed in the available repeated dose toxicity study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
